Sanda ÇALI, Gökçe AKPINAR ACET, Mahluga J. DEMİRKAPU, Medine GÜLÇEBİ İDRİZ OĞLU, Zafer GÖREN

Potential drug-drug interactions among prescriptions for elderly patients in primary health care

Background/aim: Elderly patients are at high risk from drug drug interactions (DDIs). This study evaluates the potential DDIs in Turkish elderly patients at a primary health care outpatient clinic. Materials and methods: Online database systems were used to examine DDIs on the prescriptions of patients (n = 1206). The clinical severity of DDIs was classified by the Lexi-Interact Online database. Results: Of the 5059 prescriptions, 33% were found to have DDIs. We detected 29 (0.9%) A, 380 (11.8%) B, 2494 (77.7%) C, 289 (9%) D, and 18 (0.6%) X risk rating category DDIs among the prescriptions. Prescriptions of female patients and patients aged between 65 and 72 years showed significantly higher number of DDIs. The frequency of DDIs increased both with the number of drugs and combined preparations per prescription. Acetylsalicylic acid and salbutamol were the most frequently prescribed drugs contributing to clinically important DDIs. Additionally, acetylsalicylic acid and escitalopram, which interact with each other, were found on the list of Beers criteria. The most predicted clinical outcomes of DDIs were increase in therapeutic efficacy and adverse/toxic reactions. Conclusions: Prediction of DDIs in elderly patients will provide better prescribing and drug safety. Use of nonsteroidal anti-inflammatory agents, selective serotonin reuptake inhibitors, and beta-2 adrenergic receptor agonists should be closely monitored.

PDF

___

1. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959-963.
2. Stockley HI, editor. Stockleys Drug Interactions. 5th ed. London, UK: The Pharmaceutical Press; 2001.
3. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-777.
4. Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, Beijnen JH. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drugdrug interactions. Am J Geriatr Pharmacother 2009; 7: 93-104.
5. Köberlein J, Gottschall M, Czarnecki K, Thomas A, Bergmann A, Voigt K. General practitioners views on polypharmacy and its consequences for patient health care. BMC Fam Pract 2013; 14: 119.
6. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C. Fish LS, Garber L, Kelleher M et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116.
7. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J et al. The incidence of adverse drug events in two large academic longterm care facilities. Am J Med 2005; 118: 251-258.
8. Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, LeónOrtiz M. 2012 American Geriatrics Society Beers criteria: enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the Screening Tool of Older Persons Potentially Inappropriate Prescriptions. J Am Geriatr Soc 2014; 62: 1217-1223.
9. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; 2: 564-567.
10. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Ménard JF, Bercoff E. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944-948.
11. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 2: 1652-1658.
12. Pasina L, Djade CD, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M et al. Drug-drug interactions in a cohort of hospitalized elderly patients. Pharmacoepidemiol Drug Saf 2013; 22: 1054-1060.
13. Wallace J, Paauw DS. Appropriate prescribing and important drug interactions in older adults. Med Clin North Am 2015; 99: 295-310.
14. Durrence CW, DiPiro JT, May JR, Nesbit RR Jr, Sisley JF, Cooper JW. Potential drug interactions in surgical patients. Am J Hosp Pharm 1985; 42: 1553-1555.
15. Ay P, Akici A, Harmanc H. Drug utilization and potentially inappropriate drug use in elderly residents of a community in Istanbul, Turkey. Int J Clin Pharmacol Ther 2005; 43: 195-202.
16. Yayla ME, Bilge U, Binen E, Keskin A. The use of START/ STOPP criteria for elderly patients in primary care. Scientific World Journal 2013; 12: 165873.
17. Sutherland JJ, Daly TM, Liu X, Goldstein K, Johnston JA, Ryan TP. Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions. PLoS One 2015; 10: e0118991.
18. Zhan C, Correa-de-Araujo R, Bierman AS, Sangl J, Miller MR, Wickizer SW, Stryer D. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. J Am Geriatr Soc 2005; 53: 262-267.
19. Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D, Tuccori M, Conforti A. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf 2010; 33: 667-675.
20. Yusuff KB, Okoh CN. Frequency, types and factors associated with potentially harmful drug interactions in ambulatory elderly patients in Nigeria. Int J Pharm Pract 2014; doi: 10.1111/ijpp.12167 [Epub ahead of print].
21. Marengoni A, Pasina L, Concoreggi C, Martini G, Brognoli F, Nobili A, Onder G, Bettoni D. Understanding adverse drug reactions in older adults through drug-drug interactions. Eur J Intern Med 2014; 25: 843-846.
22. Sung J, Russell RI, Nyeomans Chan FK, Chen S, Fock K, Goh KL, Kullavanijaya P, Kimura K, Lau C, Louw J et al. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract. J Gastroenterol Hepatol 2000; 5: Suppl: G58-68.
23. Klein WA, Krevsky B, Klepper L, Ljubich P, Niewiarowski TJ, Rothstein KD, Dabezies MA, Fisher RS. Nonsteroidal antiinflammatory drugs and upper gastrointestinal hemorrhage in an urban hospital. Dig Dis Sci 1993; 38: 2049-2055.
24. Younossi ZM, Strum WB, Schatz RA, Teirstein PS, Cloutier DA, Spinks TJ. Effect of combined anticoagulation and lowdose aspirin treatment on upper gastrointestinal bleeding, Dig Dis Sci 1997; 42: 79-82.
25. Perahia DG, Bangs ME, Zhang Q, Cheng Y, Ahl J, Frakes EP, Adams MJ, Martinez JM. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and postmarketing adverse event reports. Drug Healthc Patient Saf 2013; 5: 211-219.
26. Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M, Trabattoni D, Alimento M. Antihypertensive efficacy of angiotensin-converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 1998; 63: 79-86.
27. Kubacka RT, Antal EJ, Juhl RP, Welshman IR. Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects. Ann Pharmacother 1996; 30: 20-26.
28. van der Woude HJ, Zaagsma J, Postma DS, Winter TH, van Hulst M, Aalbers R. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest 2005; 127: 818-824.
29. Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, Bruno G. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci 2011; 32: 507-509.
30. Adan-Manes J, Novalbos J, López-Rodríguez R, Ayuso-Mateos JL, Abad-Santos F. Lithium and venlafaxine interaction: a case of serotonin syndrome. J Clin Pharm Ther 2006; 31: 397-400.